Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2020-06-01+56,000→ 56,000 totalExercise: $4.64Exp: 2030-05-31→ Common Shares (56,000 underlying)
Holdings
- 30,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in twelve nearly equal quarterly installments commencing on September 1, 2020.